Further attenuated Bartha strains, including those with individual deletions of TK, US3, or UL50, showed improved safety and significant anti-tumor activity in vivo, with the TK deletion strain (rPRV-ΔTK) exhibiting the best results. The gene discussed is TKT; the disease is neoplasm.